Literature DB >> 24385491

STAT3: the "Achilles" heel for AML?

Katayoun Rezvani1, John Barrett.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24385491      PMCID： PMC3879899          DOI： 10.1182/blood-2013-11-537092

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  9 in total

1.  Constitutive activity of signal transducer and activator of transcription 3 protein in acute myeloid leukemia blasts is associated with short disease-free survival.

Authors:  Mustafa Benekli; Zheng Xia; Kathleen A Donohue; Laurie A Ford; Lynda A Pixley; Maria R Baer; Heinz Baumann; Meir Wetzler
Journal:  Blood       Date:  2002-01-01       Impact factor: 22.113

2.  Inhibiting Stat3 signaling in the hematopoietic system elicits multicomponent antitumor immunity.

Authors:  Marcin Kortylewski; Maciej Kujawski; Tianhong Wang; Sheng Wei; Shumin Zhang; Shari Pilon-Thomas; Guilian Niu; Heidi Kay; James Mulé; William G Kerr; Richard Jove; Drew Pardoll; Hua Yu
Journal:  Nat Med       Date:  2005-11-20       Impact factor: 53.440

Review 3.  Small molecule inhibitors of STAT3 for cancer therapy.

Authors:  M Zhao; B Jiang; F-H Gao
Journal:  Curr Med Chem       Date:  2011       Impact factor: 4.530

4.  Repeated PR1 and WT1 peptide vaccination in Montanide-adjuvant fails to induce sustained high-avidity, epitope-specific CD8+ T cells in myeloid malignancies.

Authors:  Katayoun Rezvani; Agnes S M Yong; Stephan Mielke; Behnam Jafarpour; Bipin N Savani; Robert Q Le; Rhoda Eniafe; Laura Musse; Carol Boss; Roger Kurlander; A John Barrett
Journal:  Haematologica       Date:  2010-12-06       Impact factor: 9.941

Review 5.  Cancer vaccines and T cell therapy.

Authors:  Katayoun Rezvani; Joshua D Brody; Holbrook E Kohrt; Aaron C Logan; Ranjana Advani; Debra Katherine Czerwinski; Wen-Kai Weng; Robert S Negrin; Victoria Carlton; Malek Faham; Ronald Levy; John Barrett
Journal:  Biol Blood Marrow Transplant       Date:  2012-10-03       Impact factor: 5.742

Review 6.  STATs in cancer inflammation and immunity: a leading role for STAT3.

Authors:  Hua Yu; Drew Pardoll; Richard Jove
Journal:  Nat Rev Cancer       Date:  2009-11       Impact factor: 60.716

7.  Leukemia cell-targeted STAT3 silencing and TLR9 triggering generate systemic antitumor immunity.

Authors:  Dewan Md Sakib Hossain; Cedric Dos Santos; Qifang Zhang; Anna Kozlowska; Hongjun Liu; Chan Gao; Dayson Moreira; Piotr Swiderski; Agnieszka Jozwiak; Justin Kline; Stephen Forman; Ravi Bhatia; Ya-Huei Kuo; Marcin Kortylewski
Journal:  Blood       Date:  2013-10-29       Impact factor: 22.113

8.  Toll-like receptor 9 activation of signal transducer and activator of transcription 3 constrains its agonist-based immunotherapy.

Authors:  Marcin Kortylewski; Maciej Kujawski; Andreas Herrmann; Chunmei Yang; Lin Wang; Yong Liu; Rosalba Salcedo; Hua Yu
Journal:  Cancer Res       Date:  2009-03-03       Impact factor: 12.701

Review 9.  STAT3 activation: A key factor in tumor immunoescape.

Authors:  Cédric Rébé; Frédérique Végran; Hélène Berger; François Ghiringhelli
Journal:  JAKSTAT       Date:  2013-01-01
  9 in total
  4 in total

Review 1.  STAT3 inhibitors: finding a home in lymphoma and leukemia.

Authors:  Javier Munoz; Navjot Dhillon; Filip Janku; Stephanie S Watowich; David S Hong
Journal:  Oncologist       Date:  2014-04-04

2.  The novel Isatin analog KS99 targets stemness markers in acute myeloid leukemia.

Authors:  Charyguly Annageldiyev; Krishne Gowda; Trupti Patel; Priyanjali Bhattacharya; Su-Fern Tan; Soumya Iyer; Dhimant Desai; Sinisa Dovat; David J Feith; Thomas P Loughran; Shantu Amin; David Claxton; Arati Sharma
Journal:  Haematologica       Date:  2019-05-23       Impact factor: 9.941

3.  Cell cycle, oncogenic and tumor suppressor pathways regulate numerous long and macro non-protein-coding RNAs.

Authors:  Jörg Hackermüller; Kristin Reiche; Christian Otto; Nadine Hösler; Conny Blumert; Katja Brocke-Heidrich; Levin Böhlig; Anne Nitsche; Katharina Kasack; Peter Ahnert; Wolfgang Krupp; Kurt Engeland; Peter F Stadler; Friedemann Horn
Journal:  Genome Biol       Date:  2014-03-04       Impact factor: 13.583

Review 4.  Targeting the innate immune system as immunotherapy for acute myeloid leukemia.

Authors:  Emily Curran; Leticia Corrales; Justin Kline
Journal:  Front Oncol       Date:  2015-04-09       Impact factor: 6.244
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.